PHARMACEUTICAL WATER MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Pharmaceutical Water Market By Product Type (Highly Purified Water, Water for Injection, Water for Inhalation, Deionized water, Distilled Water, Others), By Application (Drug Formulation , Cleaning and Purification, Cell Culture Production, Equipment Cleaning , Buffers and Solutions, Others), By End User (Pharmaceutical & Biotechnology Companies, Contract Research & Manufacturing Organizations, Academics & Research Laboratories, Hospitals & Healthcare Facilities, Diagnostic Laboratories, Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

In July 2023, Nexus Pharmaceuticals, a pharmaceutical company, announced that the company’s Sterile Water for Injection, USP in 10mL and 20mL Single-Dose Vials received U.S. FDA approval
In February 2023, Evoqua Water Technologies, a water treatment company serving pharmaceutical, beverage and other industries, acquired Texas-based industrial water treatment service business of the former Bob Johnson & Associates from Kemco Systems for the expansion of the company’s presence in Texas market.
In November 2022, Merck KGaA, a global biopharmaceutical company, announced the launch of Milli-Q EQ 7008/16 ultrapure and pure water purification system. The new Milli-Q EQ 7008/16 system produces consistent ultrapure (Type 1) water quality directly from a tap water source and includes an option to obtain reverse osmosis (RO, Type 3) quality water.
In July 2022, Evoqua Water Technologies, a water treatment company serving pharmaceutical, beverage, and other industries announced the opening of new manufacturing facility in Singapore for expanding its presence in the Asia Pacific region. The new facility contributes to efforts to localise production in order to better satisfy the region's expanding need for ultrapure water solutions, namely in the microelectronics and pharmaceutical industries.